Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Cancers
|
February 25, 2023
Malignant Pleural Mesothelioma: Preliminary Toxicity Results of Adjuvant Radiotherapy Hypofractionation in a Prospective Trial (MESO-RT)
Elisabetta Parisi, Donatella Arpa, Giulia Ghigi, et al.
Cancers
|
January 16, 2020
Erratum: Passardi, A. et al<i>.</i> Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. <i>Cancers</i> 2019, <i>11</i>, 663
Alessandro Passardi, Emanuela Scarpi, Elisa Neri, et al.
Cancers
|
May 16, 2019
Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study
Alessandro Passardi, Emanuela Scarpi, Elisa Neri, et al.
Therapeutic Advances in Medical Oncology
|
December 21, 2020
Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial
Alessandro Passardi, Ilario Giovanni Rapposelli, Emanuela Scarpi, et al.
Biomolecules
|
August 27, 2021
Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies
Alessandro Passardi, Ilario Giovanni Rapposelli, Emanuela Scarpi, et al.
Frontiers in Oncology
|
April 16, 2021
Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
Donatella Arpa, Elisabetta Parisi, Giulia Ghigi, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Cancers
|
February 25, 2023
Malignant Pleural Mesothelioma: Preliminary Toxicity Results of Adjuvant Radiotherapy Hypofractionation in a Prospective Trial (MESO-RT)
Elisabetta Parisi, Donatella Arpa, Giulia Ghigi, et al.
Cancers
|
January 16, 2020
Erratum: Passardi, A. et al<i>.</i> Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. <i>Cancers</i> 2019, <i>11</i>, 663
Alessandro Passardi, Emanuela Scarpi, Elisa Neri, et al.
Cancers
|
May 16, 2019
Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study
Alessandro Passardi, Emanuela Scarpi, Elisa Neri, et al.
Therapeutic Advances in Medical Oncology
|
December 21, 2020
Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial
Alessandro Passardi, Ilario Giovanni Rapposelli, Emanuela Scarpi, et al.
Biomolecules
|
August 27, 2021
Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies
Alessandro Passardi, Ilario Giovanni Rapposelli, Emanuela Scarpi, et al.
Frontiers in Oncology
|
April 16, 2021
Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
Donatella Arpa, Elisabetta Parisi, Giulia Ghigi, et al.
Page
of 2